The results also showed a state of dyslipidemia, characterized by elevated LDL and TG and decreased HDL, which is closely linked to metabolic dysfunction in MAFLD, in addition to elevated liver enzymes (ALT, AST, and GGT), indicating hepatocellular injury. This evidence concerns the gene GPT and metabolic syndrome.